Today: 3 July 2026
Browse Category

NYSE:DD 9 November 2025 - 27 June 2026

DuPont (NYSE:DD) stock split leaves analyst target screens noisy after weekly drop

DuPont (NYSE:DD) stock split leaves analyst target screens noisy after weekly drop

U.S. cash equities do not trade on Saturday. The next regular NYSE session is Monday, with core trading set for 9:30 a.m. to 4 p.m. Eastern. Next week is shorter than usual because U.S. markets are closed Friday, July 3, for Independence Day observed. DuPont ended its first split-adjusted week down hard against materials. The Materials Select Sector SPDR Fund slipped 0.04% from Monday’s close to Friday’s close, while DD dropped 5.1% over the same span, based on listed historical prices.
27 June 2026
·
DuPont Stock Surges as 2026 Forecast Raise and $275 Million Buyback Ease Cost Fears

DuPont Stock Surges as 2026 Forecast Raise and $275 Million Buyback Ease Cost Fears

WILMINGTON, Delaware, May 5, 2026, 16:05 EDT DuPont de Nemours Inc. hiked its sales and profit outlook for 2026 on Tuesday, pairing the move with a $275 million accelerated share buyback after first-quarter numbers came in ahead of expectations, lifting shares. Net sales climbed 4% for the quarter, and the company said it plans to start the repurchase program shortly.
5 May 2026
··
Dow Jones Today: Why the Dow Is Rising as Oil Falls and Earnings Take Over

Dow Jones Today: Why the Dow Is Rising as Oil Falls and Earnings Take Over

Stocks rebounded Tuesday, with the Dow Jones Industrial Average clawing back some ground lost in Monday’s slide. The Dow added 265.17 points, or 0.54%, pushing it to 49,207.07, according to Reuters market data. The S&P 500 advanced 0.80%, and the Nasdaq Composite notched a 0.93% gain. Brent crude slumped 3.47% to $110.47, easing pressure from earlier oil spikes. Why does the rebound stand out? It comes right after the Dow plunged 1.13% to 48,941.90, a move sparked by renewed tension in the Strait of Hormuz—the key Gulf chokepoint for oil shipments. Fresh reports of conflict in the Middle East rattled risk appetite, sending the S&P 500 and Nasdaq lower as well.
5 May 2026
·····
PFAS ‘Forever Chemicals’ in Drinking Water: Louisville GenX Spike, Georgia Blood Study and Ohio Cleanup Plans Raise Alarm

PFAS ‘Forever Chemicals’ in Drinking Water: Louisville GenX Spike, Georgia Blood Study and Ohio Cleanup Plans Raise Alarm

Communities from Kentucky to Georgia to Ohio are waking up to the same unsettling reality: “forever chemicals” are showing up in their drinking water — and even in their blood — just as federal protections are being weakened and utilities scramble to catch up. On December 1, 2025, new research from the UK’s Drinking Water Inspectorate underscored how technically difficult and expensive it will be to remove these chemicals at scale, even as local U.S. stories from Louisville, Rome and Calhoun, and Shadyside lay bare how high the stakes are. Louisville Public Media+4Water Magazine+4The Times Leader+4
1 December 2025
·
DuPont (DD) Today: Citi Lifts Price Target to $47 as “New DuPont” Sets $0.20 Dividend, $2B Buyback After Qnity Spin

DuPont (DD) Today: Citi Lifts Price Target to $47 as “New DuPont” Sets $0.20 Dividend, $2B Buyback After Qnity Spin

DuPont de Nemours, Inc. headlines today with a fresh analyst target bump and continued investor focus on the company’s post‑spinoff profile, dividend reset, and buyback plans. Qnity Electronics is out; DuPont refocuses. DuPont completed the tax‑free separation of Qnity on Nov. 1. Qnity began “regular‑way” trading on Nov. 3 as NYSE: Q and was added to the S&P 500 at launch—an unusual debut that broadens index fund ownership. investors.dupont.com+1
9 November 2025
···

Stock Market Today

  • Asahi Kasei (TSE:3407) wraps up ¥17.86bn buyback, highlights pharma tech scale-up
    July 3, 2026, 4:32 PM EDT. Asahi Kasei (TSE:3407) finished a ¥17.86 billion buyback, taking in 0.75% of its shares and signaling a focus on returns for shareholders. Peptistar has now launched Asahi Kasei's FO-MD system at the plant level, putting its pharmaceutical concentration tech into real-world production. This push could drive earnings through healthcare and process solutions, adding to its main battery and hydrogen businesses. Some risks remain for executing FO-MD and AK1940 at scale. The stock has moved up, but some see valuation still lagging-with fair value estimates pointing to a possible double from here. The story here is tighter capital discipline and a bigger bet on new technology.
Go toTop